COVID-19 i in the setting of acute lymphoblastic leukaemia (case analysis, resulting in death)

A new coronaviral infection in the Russian Federation is registered less in a child treatment than in an adult one. Children’s COVID-19 is mainly asymptomatic or in mild, severe form occurs rarely. The percentage of paediatric-age patients that require in-patient medical care is from 5,7% to 20% of children with COVID-19. However, clinical observations show that children’s COVID-19 may be severe and extremely severe, also resulting in death. A risk group of unsmooth course of the new coronaviral infection is patients with serious comorbide pathology, in particular oncohematological disease, passing radiation, chemotherapy, transplantation of hematopoietic stem cells. Acute lymphoblastic leukaemia, the most frequent paediatric-age oncological disease, may be one of the factors, predisposing to severe course of the new coronaviral infection. However, COVID-19 is likely to cause the deterioration of leukaemia treatment and an adverse outcome. The article presents a clinical observation of a 12-year-old child with a critical form of the new coronaviral infection and acute lymphoblastic leukaemia in the post-transplantation period. The accumulation of COVID-19 was accompanied by deterioration in the underlying disease. Despite high-quality medical care, using modern technologies, the child had progressive deterioration with a poor outcome.

1. Министерство здравоохранения Российской Федерации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID- 19) (Временные методические рекомендации). Версия 11 (07.05.2021). 2021. 224 с. [Ministry of Health of the Russian Federation. Prevention, Diagnosis and Treatment of Novel Coronavirus Infection (COVID-19) (Interim Guidelines). Version 11 (05/07/2021). 2021. 224 p. (In Russ.)].

2. Министерство здравоохранения Российской Федерации. Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей (Методические рекомендации). Версия 2 (03.07.2020). 2020. 74 с. [Ministry of Health of the Russian Federation. Features of clinical manifestations and treatment of a disease caused by a new coronavirus infection (COVID-19) in children (Methodical recommendations). Version 2 (07/03/2020). 2020. 74 p. (In Russ.)].

3. Иванов Д.О., Заболотский Д.В., Корячкин В.А. и др. Лечение детей, инфицированных COVID-19, в непрофильном стационаре // Педиатр. 2020. Т. 11, № 2. С. 5–14. [Ivanov D.O., Zabolotskii D.V., Koryachkin V.A. et al. The treatment of children infected with COVID-19 in a non-core hospital. Pediatrician, 2020, Vol. 11, No. 2, рр. 5–14 (In Russ.)]. doi: 10.17816/PED1125–14.

4. Kelvin A.A., Halperin S. COVID-19 in children: the link in the transmission chain // The Lancet Infectious Diseases. 2020. Vol. 20, No. 6. Р. 633–634. doi: 10.1016/S1473-3099(20)30236-X.

5. Иванов Д.О., Чернова Т.М., Павлова Е.Б., Тимченко В.Н., Баракина Е.В. Коронавирусная инфекция // Педиатр. 2020. Т. 11, № 3. С. 109–117. [Ivanov D.O., Chernova T.M., Pavlova E.B., Timchenko V.N., Barakina E.V. Coronavirus infection. Pediatrician, 2020, Vol. 11, No. 3, рр. 109–117 (In Russ.)]. doi: 10.17816/PED113109-117.

6. Leidman E., Duca L.M., Omura J.D., Proia K., Stephens J.W., Sauber-Schatz E.K. COVID-19 Trends Among Persons Aged 0–24 Years — United States, March 1-December 12, 2020 // MMWR Morb Mortal wkly Rep. 2021. Vol. 70. Р. 88–94. doi: 10.15585/mmwr.mm7003e1.

7. Fernández-Sarmiento J., De Souza D., Jabornisky R. et al. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee // BMJ Paediatrics Open. 2021. Vol. 5. e000894. doi: 10.1136/bmjpo-2020-000894.

8. Лобзин Ю.В., Вильниц А.А., Костик М.М. и др. Педиатрическии мультисистемныи воспалительныи синдром, ассоциированныи с новои коронавируснои инфекциеи: нерешенные проблемы // Журнал инфектологии. 2021. Т. 13, № 1. С. 13–20. [Lobzin Yu.V., Vilnits A.A., Kostik M.M. et al. Pediatric Multisystem Inflammatory Syndrome Associated with Novel Coronavirus Infection: Unresolved Issues. Journal of Infectology, 2021, Vol. 13, No. 1, рр. 13–20 (In Russ.)]. doi: 10.22625/2072-6732-2021-13-1-13-20.

9. Валиев Т.Т., Захарова Е.В., Игнатенко О.А. и др. Дифференциальная диагностика пневмонии у детей с онкогематологическими заболеваниями в условиях новой коронавирусной инфекции COVID-19 // Российский журнал детской гематологии и онкологии. 2020. Т. 7, № 3. С. 104–111. [Valiev T.T., Zakharova E.V., Ignatenko O.A. et al. Differential diagnosis of pneumonia in children with hematological malignancies in the setting of a new coronavirus infection COVID-19. Russian Journal of Pediatric Hematology and Oncology, 2020, Vol. 7, No. 3, рр. 104–111 (In Russ.)]. doi: 10.21682/2311-1267-2020-7-3-104-111.

10. Hrusak O., Kalina T., Wolf J. et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment // Eur. J. Cancer. 2020. Vol. 132. Р. 11–16. doi: 10.1016/j.ejca.2020.03.021.

11. Liang W., Guan W., Chen R. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China // Lancet Oncol. 2020. Vol. 21, No. 3. Р. 335–337. doi: 10.1016/S1470-2045(20)30096-6.

12. Agarwal S., Jun C.H. Harnessing CAR T-cell insights to develop treatments for hyperinflammatory responses in COVID-19 patients // Cancer Discov. 2020. Vol. 10, No. 6. Р. 775–778. doi: 10.1158/2159-8290.CD-20-0473.

13. Elzembely M.M., Abdelrahman Y.S., Fadel S., Hafez H. Providing care for pediatric cancer patients in the COVID-19 era: Rapid response recommendations from a developing country // Pediatr. Blood Cancer. 2020. Vol. 67, No. 8. Р. e28467. doi: 10.1002/pbc.28467.

14. Усков А.Н., Лобзин Ю.В., Рычкова С.В. и др. Течение новой коронавирусной инфекции у детей: некоторые аспекты мониторинга заболеваемости и анализа летальности // Журнал инфектологии. 2020. Т. 12, № 3. С. 12–20. [Uskov A.N., Lobzin Yu.V., Rychkova S.V. et al. The course of a new coronavirus infection in children: some aspects of morbidity monitoring and mortality analysis. Journal of Infectology, 2020, Vol. 12, No. 3, рр. 12–20 (In Russ.)]. doi: 10.22625/2072-6732-2020-12-3-12-20.

15. Balduzzi A., Brivio E., Rovelli A. et al. Lessons after the early management of the COVID-19 outbreak in a paediatric transplant and haematooncology centre embedded within a COVID-19 dedicated hospital in Lombardia, Italy // Bone Marrow Transplant. 2020. Р. 1–6. doi: 10.1038/s41409-020-0895-4.

16. Hunger S.P., Mullighan C.G. Acute lymphoblastic leukemia in children // New England Journal of Medicine. Massachussetts Medical Society. 2015. Vol. 373, No. 16. Р. 1541–1552. doi: 10.1056/nejmral1400972.

17. Rabin K.R., Gramatges M.M., Margolin J.F. Acute lymphoblastic leukemia // Principles and Practice of Pediatric Oncology. 7th ed. 2015. P. 463–497.

18. Cooper S.L., Brown P.A. Treatment of pediatric acute lymphoblastic leukemia // Pediatric Clinics of North America. 2015. Vol. 62, No. 1. Р. 61– 73. doi: 10.1016/j.pcl.2014.09.006.